Met Life Investment Management, LLC Guardant Health, Inc. Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 68,147 shares of GH stock, worth $1.98 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
68,147
Previous 68,147
-0.0%
Holding current value
$1.98 Million
Previous $1.97 Million
20.63%
% of portfolio
0.01%
Previous 0.01%
Shares
46 transactions
Others Institutions Holding GH
# of Institutions
323Shares Held
127MCall Options Held
844KPut Options Held
2.38M-
Vanguard Group Inc Valley Forge, PA11.7MShares$341 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$327 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA10.1MShares$295 Million0.04% of portfolio
-
Cadian Capital Management, LP New York, NY6.93MShares$202 Million8.13% of portfolio
-
Deep Track Capital, LP Greenwich, CT6MShares$175 Million5.07% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $2.98B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...